
Cancer remains one of the leading causes of death worldwide, accounting for approximately one-sixth of all deaths [1]. In 2022, there were an estimated 20 million new cancer cases and 9.7 million cancer-related deaths globally. By 2050, the global cancer incidence is projected to exceed 35 million cases,...

PDAC, representing approximately 85% of pancreatic malignancies, ranks among the most lethal solid tumors with a 5-year survival rate below 10%. Surgical resection is the only curative treatment for this disease [1, 2, 3–4]. Although surgical resection remains the sole curative option, over 80%...

Lung cancer in never-smokers (LCINS) presents a distinct epidemiological profile in Asia, with a higher proportion of cases occurring in never-smoking women. This review examines the evidence for lung cancer screening in this population, synthesizing data on risk factors, LDCT screening, and current...

Sarcopenia, defined as the loss of muscle mass accompanied by reduced strength and/or physical performance, is associated with numerous health risks, including falls, complications, prolonged hospitalization, and increased mortality. In cancer patients, sarcopenia is not only age-related but also aggravated...